IBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease
The UAE becomes Anktiva’s fifth regulatory jurisdiction, expanding its footprint to 34 countries and boosting ImmunityBio’s global push. The UAE granted Anktiva its broadest approval yet across bladder and metastatic lung cancer. In the U.S., ImmunityBio is seeking a similar papillary-only label expansion, with an FDA decision due Jan. 6, 2027. Trial data showed Anktiva … Read more